Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Scherer

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Nature Communications|November 15, 2016
Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patientsJacob J Chabon, Andrew D Simmons, Alexander F Lovejoy, et al.
Science Translational Medicine|November 11, 2016
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNAFlorian Scherer, David M Kurtz, Aaron M Newman, et al.
Blood|April 19, 2015
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencingDavid M Kurtz, Michael R Green, Scott V Bratman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2022
Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain LymphomasJurik A Mutter, Stefan K Alig, Mohammad S Esfahani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2019
Reply to J. Wang et alDavid M Kurtz, Florian Scherer, Michael C Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2018
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell LymphomaDavid M Kurtz, Florian Scherer, Michael C Jin, et al.
The Lancet. Haematology|February 1, 2024
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trialElisabeth Schorb, Lisa Kristina Isbell, Andrea Kerkhoff, et al.
NPJ Precision Oncology|August 14, 2024
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumorsJulia C Kuehn, Patrick Metzger, Nicolas Neidert, et al.
Hemasphere|June 24, 2026
Spatial and multi-omic profiling reveals pericyte-derived CCL19 as a key prognostic factor in CNS lymphomaJulia C Kuehn, Lauritz Miarka, Roman Sankowski, et al.
Cancer Discovery|September 14, 2017
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA ProfilingAadel A Chaudhuri, Jacob J Chabon, Alexander F Lovejoy, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Nature Communications|November 15, 2016
Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patientsJacob J Chabon, Andrew D Simmons, Alexander F Lovejoy, et al.
Science Translational Medicine|November 11, 2016
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNAFlorian Scherer, David M Kurtz, Aaron M Newman, et al.
Blood|April 19, 2015
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencingDavid M Kurtz, Michael R Green, Scott V Bratman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2022
Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain LymphomasJurik A Mutter, Stefan K Alig, Mohammad S Esfahani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2019
Reply to J. Wang et alDavid M Kurtz, Florian Scherer, Michael C Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2018
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell LymphomaDavid M Kurtz, Florian Scherer, Michael C Jin, et al.
The Lancet. Haematology|February 1, 2024
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trialElisabeth Schorb, Lisa Kristina Isbell, Andrea Kerkhoff, et al.
NPJ Precision Oncology|August 14, 2024
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumorsJulia C Kuehn, Patrick Metzger, Nicolas Neidert, et al.
Hemasphere|June 24, 2026
Spatial and multi-omic profiling reveals pericyte-derived CCL19 as a key prognostic factor in CNS lymphomaJulia C Kuehn, Lauritz Miarka, Roman Sankowski, et al.
Cancer Discovery|September 14, 2017
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA ProfilingAadel A Chaudhuri, Jacob J Chabon, Alexander F Lovejoy, et al.
Pageof 6